Retatrutide: A Doctor's Honest Guide to the Newest Weight Loss Drug (and Why Not to Buy It Online)
Bar chart of average weight loss at 80 weeks in the TRIUMPH-1 trial of retatrutide: 28.3% on 12 mg, 25.9% on 9 mg, 19.0% on 4 mg, and 2.2% on placebo, with a note that retatrutide is not FDA-approved.